High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

NCT02551718 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
34
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University of Washington

Collaborators